
The insurer topped quarterly estimates as revenue rose to about $40.9 billion and Medicare Advantage grew 20.7%, but it kept its 2026 adjusted profit outlook at at least $9 per share, disappointing some investors even as Evercore ISI upgraded the stock to Outperform.
Humana reported second-quarter results above Wall Street expectations, posting adjusted earnings of $7.61 per share and revenue of about $40.9 billion as medical spending tracked in line with the insurer's forecasts. Net income rose to $694 million, or $5.73 per share, from $545 million, or $4.51 per share, a year earlier. The company maintained its 2026 adjusted profit outlook of at least $9 per share rather than raising it, even as Medicare Advantage growth reached 20.7% and some peers have increased guidance, contributing to shares falling more than 4% in premarket trading. After the results, Evercore ISI upgraded Humana to Outperform. Humana's medical benefit ratio was 91.2%, matching analyst expectations and company forecasts but up from 89.9% a year earlier.